CHANNING PALLER, M.D.
Medical Oncology Physician in WASHINGTON, District of Columbia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
CHANNING PALLER, M.D. reported a CMS MIPS final score of 74.3962/100 — below the 83.1 national average — and filed 544 Medicare Part D claims in 2023.
- 74.3962/100
- MIPS score · -9 vs avg
- 544
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
CHANNING PALLER, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
74 12th percentile higher than 12% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
CHANNING PALLER, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about CHANNING PALLER, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in District of Columbia
How Medical Oncology Physician compares to other specialties among District of Columbia providers
Medical Oncology Physician share within District of Columbia
Medical Oncology Physician is one of the more visible NUCC categories in District of Columbia
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
CHANNING PALLER, M.D.'s 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 74.3962/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical Oncology Physician) — 74.3962/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Medical Oncology Physician US NPIs
74.3962/100 MIPS final score — 8.7 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Medical Oncology Physician. Quality dim: 64.7185. Cost dim: 52.4354.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
CHANNING PALLER, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 5255 LOUGHBORO ROAD, WASHINGTON, DC, 20016, with a listed phone of (410) 955-7963. NPI 1356487763 was issued on 01/30/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PALLER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 544 prescription claims written by this provider, covering 82 Medicare beneficiaries and totaling roughly $1.2 million in drug spend, with an opioid prescribing rate of 2.6%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.3962/100 for the 2023 performance year (Quality 64.7185, Cost 52.4354), compared with the national average of 83.1.
Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1356487763 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 01/30/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm CHANNING PALLER, M.D.'s current license status, disciplinary history, and board certifications with the D.C. Board of Medicine in District of Columbia before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where CHANNING PALLER, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHANNING PALLER, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.2K
Largest payer
PFIZER INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 771
- Total Day Supply
- 22,202
- Generic Drug Cost
- $329K
- Opioid Claims
- 14 (2.6% rate)
Patient Demographics
- Average Patient Age
- 76.3 years
- Avg HCC Risk Score
- 2.47
- Gender Split
- 21% female / 79% male
- Age Distribution
- <65: 0, 65-74: 36, 75-84: 33, 85+: 13
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What CHANNING PALLER, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Abiraterone Acetate
Abiraterone Acetate
176 claims
- Prednisone
Prednisone
129 claims
- Xtandi 39
Xtandi
39 claims
- Nubeqa 33
Nubeqa
33 claims
- Bicalutamide 18
Bicalutamide
18 claims
- Letrozole 17
Letrozole
17 claims
- Erlotinib Hcl 12
Erlotinib Hcl
12 claims
- Dexamethasone 11
Dexamethasone
11 claims
| Drug | Claims |
|---|---|
| Abiraterone Acetate | 176 |
| Prednisone | 129 |
| Xtandi Enzalutamide | 39 |
| Nubeqa Darolutamide | 33 |
| Bicalutamide | 18 |
| Letrozole | 17 |
| Erlotinib Hcl | 12 |
| Dexamethasone | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How CHANNING PALLER, M.D. fits within the Medical Oncology Physician landscape nationally.
CHANNING PALLER, M.D.'s 544 claims are below the specialty average of 689.
Nearby Medical Oncology Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as PALLER.
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore District of Columbia
Frequently Asked Questions
What is CHANNING PALLER, M.D.'s specialty? ▼
How much does CHANNING PALLER, M.D. prescribe under Medicare Part D? ▼
What is CHANNING PALLER, M.D.'s Medicare quality score? ▼
Where is CHANNING PALLER, M.D. located? ▼
What is CHANNING PALLER, M.D.'s NPI number? ▼
Does CHANNING PALLER, M.D. prescribe opioids? ▼
How many Medical Oncology Physician providers are there in the US? ▼
What drugs does CHANNING PALLER, M.D. prescribe most often? ▼
Does CHANNING PALLER, M.D. accept Medicare? ▼
How can I verify CHANNING PALLER, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology